T 2106/10 (Tenascin binding to fibronectin/Novartis Forschungsstiftung) of 4.2.2014

European Case Law Identifier: ECLI:EP:BA:2014:T210610.20140204
Date of decision: 04 February 2014
Case number: T 2106/10
Application number: 02776926.4
IPC class: A61K 38/39
A61K 38/16
C07K 16/18
G01N 33/50
G01N 33/574
A61P 35/00
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 295 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
Applicant name: Novartis Forschungsstiftung, Zweigniederlassung
Opponent name: -
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention Art 84
European Patent Convention Art 111(1)
European Patent Convention Art 101(3)(a)
Keywords: Reimbursement of appeal fee - (no)
Claims - clarity
Claims - main request (no)
Claims - clarity
Claims - auxiliary request (no)
Catchwords:

-

Cited decisions:
G 0010/93
T 0645/11
Citing decisions:
T 0595/15

7 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

EPO Guidelines - G Patentability

Case Law Book: V Priority

Case Law of the Enlarged Board

General Case Law